Apimeds Pharmaceuticals US Inc
APUS | AMEX
$3.00
$0.00 (-0.17%)
Nov 2, 2026, 11:55 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q4 2022 Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 278.37K | 979.53K | 1.64M | 6.99M | 8.74M | 250.34K | 3.46K | 26.57K | 63.33K | 147.38K | 410.48K | 751.05K | 6.17K |
Short-Term Investments | n/a | 1.5M | 2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | 149.89M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 116.74M | 127.84M | 75.49K | 129.74K | 184K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 10.4M | 10.67M | 8.05M | 2.1M | n/a | n/a | 9.6K | 10.34K | 10.34K | 10.34K | 11.6K | n/a | n/a |
Total Current Assets | 10.68M | 13.15M | 13.98M | 9.09M | 10.35M | 259.9K | 13.06K | 36.91K | 73.66K | 157.72K | 422.08K | 922.73K | 6.17K |
Property-Plant & Equipment | 208.09K | 228.37K | 239.02K | 34.19K | 13.14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 116.95M | 128.07M | 150.2M | 163.93K | 197.13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Assets | 127.62M | 141.22M | 164.18M | 9.25M | 10.55M | 259.9K | 13.06K | 36.91K | 73.66K | 157.72K | 422.08K | 922.73K | 6.17K |
Account Payables | n/a | n/a | 918.65K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.6K | 36.88K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 14.48M | 9.36M | 7.59M | 500K | 500K | 623.62K | 250K | 250K | 100K | n/a | n/a | 315K | 260K |
Other Current Liabilities | 6.59M | 1.58M | 1.62M | 18.25K | 182.66K | 287.05K | 180.55K | 77K | 26K | n/a | n/a | 0 | n/a |
Total Current Liabilities | 21.07M | 14.58M | 10.71M | 1.09M | 809K | 1.77M | 1.02M | 761.4K | 488.17K | 136.48K | 123.31K | 377.07K | 319.78K |
Long-Term Debt | 101.87K | 118.82K | n/a | n/a | n/a | 250K | 346.84K | 321.99K | 299.46K | 285.84K | 266.89K | 400K | 400K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 101.87K | 118.82K | 129.45K | n/a | n/a | 250K | 346.84K | 321.99K | 299.46K | 285.84K | 266.89K | 400K | 400K |
Total Liabilities | 21.18M | 14.7M | 10.84M | 1.09M | 809K | 2.02M | 1.37M | 1.08M | 787.63K | 422.32K | 390.21K | 777.07K | 719.78K |
Total Debt | 14.58M | 9.53M | 7.76M | 500K | 500K | 873.62K | 596.84K | 571.99K | 399.46K | 285.84K | 266.89K | 715K | 660K |
Book Value | 106.45M | 126.52M | 153.35M | 8.16M | 9.74M | -1.76M | -1.36M | -1.05M | -713.97K | -264.6K | 31.87K | 145.66K | -713.61K |
Book Value Per Share | 65.19 | 81.55 | 140.92 | 64.89 | 93.91 | -15.21 | -10.70 | -8.24 | -5.62 | -2.08 | 0.25 | 1.15 | -5.62 |
Common Stock | 1.51K | 125.76K | 125.76K | 125.76K | 125.76K | 79.04K | 79.04K | 205.5K | 205.5K | 205.5K | 205.5K | 150K | 100K |
Retained Earnings | -65.63M | -45.45M | -10.39M | -9.24M | -7.46M | -4.79M | -4.39M | -4.08M | -3.75M | -3.3M | -3M | -2.43M | -2.22M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 106.45M | 126.52M | 153.35M | 8.16M | 9.74M | -1.76M | -1.36M | -1.05M | -713.97K | -264.6K | 31.87K | 145.66K | -713.61K |
Total Investments | n/a | 1.5M | 151.89M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove APUS